HOME >> BIOLOGY >> NEWS
Infused spleen cells found not to impact islet recovery and reversal of type 1 diabetes in mice

BOSTON Researchers from Joslin Diabetes Center have published in the March 24, 2006, issue of the journal Science a significant study about islet cell recovery and reversal of type 1 diabetes in mice.

It is generally believed that an effective cure for type 1 diabetes will require two substantial scientific advances. First, in order to restore the pancreas' ability to produce insulin, new islet beta cells must be provided, either by transplanting cells from a healthy donor or by encouraging the growth and/or function of the diabetic patient's own cells. Second, to protect the new beta cells, no matter what their origin, it is necessary to repair the breakdown in immunological tolerance that precipitated the anti-islet attack in the first place.

In a widely discussed paper that appeared in Science in 2003, Dr. Denise Faustman and her colleagues reported successful achievement of both of these advances, resulting in the "cure" of a substantial fraction of severely diabetic NOD mice, the most popular animal model of human type 1 diabetes. Their method entailed giving diabetic mice a temporary islet transplant from a genetically identical mouse, administering a single injection of an immuno-stimulatory compound called Complete Freund's Adjuvant (CFA), and repeatedly injecting a large number of spleen cells taken from genetically different mice. It was thought that the islets served to keep the animals with diabetes healthy long enough for the other treatments to have their effects, that the CFA eliminated the autoimmune attack on the islets, and that the spleen cells somehow gave rise to insulin-producing cells, presumably beta-cells, ultimately leading to islet regeneration.

"The compound CFA has been used to modulate diabetes in NOD mice for a number of years in a variety of experimental contexts, so its effect was not very surprising. However, the notion that adult spleen cells from one mouse could give rise to new islets in the pancreas o
'"/>


23-Mar-2006


Page: 1 2 3 4

Related biology news :

1. Newly created cancer stem cells could aid breast cancer research
2. ESF EURYI award winner aims to stop cancer cells reading their own DNA
3. OHSU turns mouse into factory for human liver cells
4. UCLA scientists produce functioning neurons from human embryonic stem cells
5. UCF research links proteins, stem cells and potential Alzheimers treatment
6. Teamwork between 2 key proteins necessary for normal development and regulation of red blood cells
7. In a first, Einstein scientists discover the dynamics of transcription in living mammalian cells
8. How cells change the pace of their steps
9. Discredited Korean embryonic stem cells true origins revealed
10. A low expression of MX2 gene exists in the white blood cells of narcoleptics
11. Penn researchers discover pathway that eliminates genetic defects in red blood cells

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/19/2019)... ... , ... Nativis, Inc., today announced the Company has changed ... immediately for the clinical stage, therapeutic device company, which is developing non-invasive treatments ... Rivera, Chief Executive Officer, said, “the renaming of the company to EMulate Therapeutics, ...
(Date:3/18/2019)... ... March 18, 2019 , ... uBiome, the ... and the third highest quality portfolio following Seres Health and Nestle, as published ... Moser, and Theodor Myfleler. uBiome executives Dr. Jessica Richman, PhD, co-founder and CEO, ...
(Date:3/18/2019)... ... , ... Early engagement not only improves and makes research ... by better balancing scientific objectives with patient goals. , Reaching out to patient ... from development to market. Involving these groups in this manner ensures better information ...
Breaking Biology News(10 mins):
(Date:3/19/2019)... Israel and BASEL, Switzerland (PRWEB) , ... ... ... Sheba Medical Center at Tel HaShomer, the largest hospital in Israel and ... develop point-of-care cell-therapy manufacturing using the state-of-the-art Cocoon™ manufacturing platform. The partnership ...
(Date:3/15/2019)... ... March 15, 2019 , ... ... and affiliate companies including AVAPCO LLC and API Intellectual Properties Holdings. The ... and R&D center in Thomaston, Georgia, operations, research, and business development staff ...
(Date:3/14/2019)... ROCK, Ark. (PRWEB) , ... March 14, 2019 ... ... America’s 29th Annual Conference & Expo, themed “Navigating the Full Spectrum of Case ... Vegas, NV, June 10-14, 2019. This conference is the only case management industry ...
(Date:3/14/2019)... ... March 13, 2019 , ... The International Society for ... taking place in Brussels, Belgium on 25–26 September 2019. This event is a ... innovative approaches. , “Biopharmaceuticals have become a main pillar in the pharmaceutical ...
Breaking Biology Technology:
Cached News: